Logotype for Quanterix Corporation

Quanterix (QTRX) investor relations material

Quanterix Canaccord Genuity’s 45th Annual Growth Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Quanterix Corporation
Canaccord Genuity’s 45th Annual Growth Conference summary13 Aug, 2025

Business performance and guidance

  • Core business expected to decline meaningfully in 2025, with academic revenues down 18% and pharma impacted by smaller accelerator projects.

  • Consumables business remains resilient, with only a 4% year-over-year decline, and spatial business achieved its largest ever consumables quarter.

  • Accelerator business saw a 60% year-over-year revenue drop due to smaller project sizes and reduced biopharma spending, despite more trials and new customers.

  • Akoya's revenue decline attributed to CDx milestone timing and macroeconomic factors, with a projected annualized revenue of $65M.

  • Guidance has been pressure tested for current macro conditions, with potential upside if the environment improves.

Strategic initiatives and synergies

  • Integration of Akoya aims to create a unified company with one leadership and commercial team, focusing on assay development and expanding technology systems.

  • Targeting $85M in annualized run-rate synergies by 2026, with 75% already implemented, and a single operating footprint for efficiency.

  • Cash flow breakeven targeted for 2026, achievable even if macro conditions remain unchanged, driven by cost synergies.

  • R&D investment increased to 30% of revenues, focusing on customer continuity and growth.

Product development and innovation

  • Launching the Simoa One platform with enhanced sensitivity and multiplexing, targeting immunology and oncology applications.

  • Simoa One reagents to be made available to a broader flow cytometer installed base in 2026, enabling wider research access.

  • Lucent AD Complete, a five-marker Alzheimer's diagnostic test, is advancing toward FDA submission and Medicare reimbursement, with additional clinical utility studies planned.

  • New progression markers (205 and 212) launched for neurofibrillary tangle detection, enhancing diagnostic and monitoring capabilities.

  • Ongoing expansion of assay menu, leveraging synergies between neuro and oncology, and focusing on high-throughput, easy-to-use solutions.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Quanterix earnings date

Logotype for Quanterix Corporation
Q3 202511 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Quanterix earnings date

Logotype for Quanterix Corporation
Q3 202511 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's proprietary platform offers high sensitivity to detect various proteins at concentrations as low as one part per trillion. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage